At the end of the quarter, GEV had a $7.4 billion cash balance, up from $5.8 billion in the second quarter of 2024. Also Read: GE Vernova Vs. GE Healthcare: Betting On Power Or Medical Tech To Lead AI ...
“At the Valuing Life Medicines Access Summit, a range of key conversations were had around several core issues. As a result of this collaborative multi-stakeholder dialogue both solutions and ...
Discover how two health systems are testing GE HealthCare's AI tool, CareIntellect for Oncology, to streamline oncology notes and improve patient care.